National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Lung Cancer Prevention (PDQ®)
Patient Version   Health Professional Version   Last Modified: 10/03/2008



Purpose of This PDQ Summary






Summary of Evidence






Significance






Evidence of Benefit






Get More Information From NCI






Changes To This Summary (10/03/2008)






Questions or Comments About This Summary






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Summary of Evidence

Smoking Avoidance
Smoking Cessation
Beta Carotene
Radon Exposure
Vitamin E/Tocopherol

Note: Separate PDQ summaries on Lung Cancer Screening; Small Cell Lung Cancer Treatment; Non-Small Cell Lung Cancer Treatment and Prevention and Cessation of Cigarette Smoking: Control of Tobacco Use are also available.

Smoking Avoidance

Based on solid evidence, cigarette smoking causes lung cancer and therefore, smoking avoidance would result in decreased mortality from primary lung cancers.

Description of the Evidence

  • Study Design: Evidence obtained from a randomized controlled trial.
  • Internal Validity: Good.
  • Consistency: Good.
  • Magnitude of Effects on Health Outcomes: Decreased risk, large magnitude.
  • External Validity: Good.
Smoking Cessation

Based on solid evidence, long-term sustained smoking cessation results in decreased incidence of lung cancer and of second primary lung tumors.

Description of the Evidence

  • Study Design: Evidence obtained from case-control and cohort studies.
  • Internal Validity: Good.
  • Consistency: Good.
  • Magnitude of Effects on Health Outcomes: Decreased risk, moderate magnitude.
  • External Validity: Good.
Beta Carotene

Based on solid evidence, high-intensity smokers who take pharmacological doses of beta carotene have an increased lung cancer incidence and mortality that is associated with taking the supplement.

Description of the Evidence

  • Study Design: Evidence obtained from randomized controlled trials.
  • Internal Validity: Good.
  • Consistency: Good.
  • Magnitude of Effects on Health Outcomes: Increased risk, small magnitude.
  • External Validity: Good.
Radon Exposure

Based on solid evidence, exposure to radon increases lung cancer incidence and mortality.

Description of the Evidence

  • Study Design: Evidence obtained from case-control and cohort studies.
  • Internal Validity: Fair.
  • Consistency: Good.
  • Magnitude of Effects on Health Outcomes: Increased risk that follows a dose-response gradient, with small increases in risk for levels experienced in most at-risk homes.
  • External Validity: Fair.
Vitamin E/Tocopherol

Based on solid evidence, taking vitamin E supplements does not affect the risk of lung cancer.

Description of the Evidence

  • Study Design: Evidence obtained from four randomized controlled trials.
  • Internal Validity: Good.
  • Consistency: Fair.
  • Magnitude of Effects on Health Outcomes: Strong evidence of no association.
  • External Validity: Good.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov